Tibsovo 250 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MF7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,201
Award facts
- Contract value 100% obligated
- $46,200.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $46,200.62 to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 21, 2026, for the supply of TIBSOVO 250 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 11, 2026, and performance will be executed from the vendor's location in Conshohocken, Pennsylvania. TIBSOVO (ivosidenib) is an oral oncology medication used in the treatment of certain hematologic malignancies, reflecting the pharmaceutical distributor's critical role in supplying specialized medical products to federal healthcare systems.
This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC vehicle enables the delivery of a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally, including service to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. As a major pharmaceutical distributor, Cencora/Amerisourcebergen consistently demonstrates its capability to meet federal procurement requirements through competitive, open competition contracting for essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26F9MF7?
SPE2DR26F9MF7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MF7 worth?
The government has obligated $46,201 on SPE2DR26F9MF7.
Is contract SPE2DR26F9MF7 an order under another contract?
Yes. SPE2DR26F9MF7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MF7 competed?
The extent of competition for SPE2DR26F9MF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award